Embryopathy in infant conceived one year after termination of maternal etretinate.
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000015:Abnormalities, Multiple / Q000139:chemically induced*; D000328:Adult; D005050:Etretinate / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011565:Psoriasis / Q000188:drug therapy; D013997:Time Factors
D005050:Etretinate